To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Departmental Publication (Transparency)
Ministry of Defence

Mar. 19 2024

Source Page: FOI responses published by MOD: week commencing 18 March 2024
Document: Joining the Royal Navy with spinal surgery for Scheuremann's disease (JSP 950) (PDF)

Found: 1 Includes oral steroids, repeated courses of antibiotics

Bill Documents
15 Mar 2024 - Briefing papers
Research Briefing on the Bill
Trade (Comprehensive and Progressive Agreement for Trans-Pacific Partnership) Act 2024

Found: He added there we re concerns about antibiotic resistance due to excessive use of antibiotics in several

Select Committee
Government's response to the Science, Innovation and Technology Committee's report 'The antimicrobial potential of bacteriophages'

Government Response Mar. 14 2024

Committee: Science, Innovation and Technology Committee

Found: the potential to be used as an antimicrob ial, either in conjunction with, or as an alternative to, antibiotics

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 29 May 2023
Document: FOI 23/351 - attachment 1 (PDF)

Found: portive treatment, but other serious infections may require medical intervention such as treatment with antibiotics

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 1 (PDF)

Found: saw the nurse on thinking it was an ear infect ion and stated antibiotics, over the weekend the pain

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 2 (PDF)

Found: and diabetes; JAK2 -mutation posi tive essent ial thrombocy themia, breast cancer in remissio n, and antibiotics

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 9 (PDF)

Found: Analgesics Antibiotics Antiviral medications Corticosteroids Non-steroidal anti -inflammatory drugs

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 8 (PDF)

Found: We o bserve dhigher use of antibiotics, NSAI s, and p sychotropics in SIDIAPcompared with PHARMO .

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 6 (PDF)

Found: Analgesics Antibiotics Antiviral medications Corticosteroids Non-steroidal anti -inflammatory drugs

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 18 December 2023
Document: FOI 23/905 - attachment 7 (PDF)

Found: ear before time zero (prescriptions or dispensing, no over-the-counter medication use) Analges ics Antibiotics